• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFR14A filed by Ingevity Corporation

    3/22/24 4:21:00 PM ET
    $NGVT
    Major Chemicals
    Industrials
    Get the next $NGVT alert in real time by email
    DEFR14A 1 lngvt2024_defr14a.htm INGEVITY CORP - DEFR14A INGEVITY CORPORATION - DEF 14A
     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a)

    of the Securities Exchange Act of 1934

    (Amendment No. 1)

     

    Filed by the Registrant

     

    Filed by a Party other than the Registrant

     

    Check the appropriate box:

     

      Preliminary Proxy Statement
         
      Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
         
      Definitive Proxy Statement
         
      Definitive Additional Materials
         
      Soliciting Material under to §240.14a-12

     

    INGEVITY CORPORATION

     

     

     

     

    (Name of Registrant as Specified In Its Charter)

     

    Not Applicable

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check all boxes that apply):

     

      No fee required.
         
      Fee paid previously with preliminary materials.
         
      Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     
     

     

    EXPLANATORY NOTE

     

    On March 11, 2024, Ingevity Corporation (“Ingevity,” the “Company” or “us”) filed a definitive proxy statement (the “Proxy Statement”) with the U.S. Securities and Exchange Commission in connection with the Company’s 2024 annual meeting of stockholders (the “Annual Meeting”) scheduled to be held virtually via live audio webcast on April 23, 2024, at 9:30 a.m. Eastern Time.

     

    This Amendment (this “Amendment”) to the Proxy Statement is being made available, beginning on March 22, 2024, to the Company’s stockholders of record as of February 26, 2024 for use at the Annual Meeting. This Amendment should be read in conjunction with the Proxy Statement.

     

    Except as described in the “Changes to Proxy Statement” section of this Amendment, below, the information provided in the Proxy Statement remains unchanged and continues to apply. To the extent the information in this Amendment differs from or updates information contained in the Proxy Statement, the information in this Amendment shall control. Unless expressly defined in this Amendment, all defined terms used in this Amendment have the same meaning given to them in the Proxy Statement. A copy of the Proxy Statement is available on the internet at https://ir.ingevity.com/financial-information/sec-filings/default.aspx, or on the SEC’s EDGAR system at https://www.sec.gov/edgar.

     

    CHANGES TO PROXY STATEMENT

     

    The Proxy Statement erroneously stated the vote that is required to approve Proposal 4 regarding an amendment to the Company’s Certificate of Incorporation (the “Charter Amendment”). This Amendment is being provided to correct those statements in the Proxy Statement by replacing them with disclosures correctly stating the vote required to approve the Charter Amendment.

     

    The disclosure provided under the caption “Vote required” on page 81 of the Proxy Statement is hereby amended and restated in its entirety to read as follows:

     

    “The affirmative vote of a majority of the outstanding shares of Common Stock entitled to vote is required for the approval of the Charter Amendment.”

     

    The disclosure and related table provided under the caption “What proposals will be voted on at the Annual Meeting, what are the Board’s voting recommendations, and what is required for a proposal to pass?” on page 87 of the Proxy Statement is hereby amended and restated in its entirety to read as follows:

     

    “The following table summarizes the Board’s voting recommendations for each proposal, the vote required for each proposal to pass, and the effect of abstentions and uninstructed shares on each proposal. If you are a stockholder of record who submits a proxy card without selecting an option for any of the proposals, the proxy holders will vote in accordance with the Board recommendations in the table below.

     

    INGEVITY | 2024 Proxy Statement – Amendment No. 1           1
     

    Proposal       Description       Board
    Voting
    Recomm-
    endation
          Vote
    Required
    to
    Pass(1)
          Effect of
    Abstentions
    on
    Votes Cast(2)
          Effect
    of
    Broker
    Non-votes(3)
    1   Election of Nine Directors  

    FOR

    all director nominees

      Majority of the votes cast   None   None
    2   Advisory Vote on Compensation of our Named Executive Officers (Say-On-Pay)   FOR   Majority of shares present   Counts as a vote against the proposal   None
    3   Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2024   FOR   Majority of shares present   Counts as a vote against the proposal   Broker may vote in its discretion
    4   Amendment of the Company’s Certificate of Incorporation to provide for the exculpation of certain officers from liability in limited circumstances   FOR  

    Majority of outstanding shares

      Counts as a vote against the proposal   Counts as a vote against the proposal

     

    (1) For Proposal 1, “majority of votes cast” means that the number of votes cast “for” a director nominee must exceed the number of votes cast “against” the director nominee. For Proposals 2 and 3, “shares present” includes abstentions.  For Proposal 4, “majority of outstanding shares” means the affirmative vote of a majority of the outstanding shares of Common Stock entitled to vote.
    (2) Abstentions are considered present and entitled to vote.
    (3) Brokers only have authority to vote in their discretion for routine matters. All of the proposals, except for Proposal 3, are considered non-routine matters. If you are a beneficial owner holding shares through a broker and you do not specify a choice to your broker for a non-routine proposal, the broker is not entitled to vote in its discretion and this is considered a broker non-vote.”

     

    SUPPLEMENTAL INFORMATION

     

    If you have already returned your proxy or voting instruction form or provided voting instructions in the manner prescribed by your bank or broker, you do not need to take any action unless you wish to change your vote.

     

    If you are a stockholder of record, you may revoke your proxy and change your vote at any time before the polls close at the Annual Meeting by doing one of the following:

     

    ■ Voting again by telephone or via the Internet prior to 11:59 p.m., Eastern Time, on April 22, 2024;
    ■ Giving written notice to the Corporate Secretary of the Company;
    ■ Delivering a later-dated proxy to the Company; or
    ■ Voting during the Annual Meeting by following the instructions available on the meeting website, www.virtualshareholdermeeting.com/NGVT2024.

     

    If you are a beneficial owner, please check your voting instruction form or contact the bank or broker that holds your shares for instructions on how to revoke or change your voting instruction.

     

    INGEVITY | 2024 Proxy Statement – Amendment No. 1           2
     
    Get the next $NGVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NGVT

    DatePrice TargetRatingAnalyst
    2/26/2025$62.00 → $65.00Market Perform → Outperform
    BMO Capital Markets
    8/7/2024$58.00Market Perform → Market Outperform
    CJS Securities
    4/22/2024$52.00 → $62.00Hold → Buy
    Jefferies
    11/6/2023$49.00Market Outperform → Market Perform
    CJS Securities
    10/3/2023$62.00 → $53.00Buy → Hold
    Loop Capital
    8/7/2023$71.00 → $60.00Outperform → Market Perform
    BMO Capital Markets
    7/27/2023$64.00 → $75.00Hold → Buy
    Loop Capital
    5/5/2023$92.00 → $64.00Buy → Hold
    Loop Capital
    More analyst ratings

    $NGVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Segal Francis David was granted 396 shares, increasing direct ownership by 7% to 6,051 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    1/6/26 1:39:45 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Director Willis J Kevin was granted 479 shares, increasing direct ownership by 6% to 8,779 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    1/6/26 1:38:10 PM ET
    $NGVT
    Major Chemicals
    Industrials

    New insider Clontz Clarence Reid Jr. claimed ownership of 7,029 shares (SEC Form 3)

    3 - Ingevity Corp (0001653477) (Issuer)

    12/18/25 6:13:09 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    SEC Filings

    View All

    Ingevity Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure

    8-K - Ingevity Corp (0001653477) (Filer)

    1/5/26 6:39:42 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Ingevity Corp (0001653477) (Filer)

    12/8/25 6:56:30 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Ingevity Corp (0001653477) (Filer)

    12/8/25 6:54:59 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ingevity upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously

    2/26/25 7:15:06 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by CJS Securities with a new price target

    CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00

    8/7/24 9:18:13 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by Jefferies with a new price target

    Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously

    4/22/24 7:39:26 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ingevity announces dates for fourth quarter and full year 2025 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its fourth quarter and full year 2025 earnings after the stock market close on Wednesday, February 25, 2026. The company will host a live webcast on Thursday, February 26, at 10:00 a.m. (Eastern) to discuss fourth quarter and full year 2025 fiscal results. The webcast can be accessed via the investors section of Ingevity's website. Participants may pre-register for the event here. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 102386. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recordin

    2/11/26 9:15:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity named to 2026 America's Most Responsible Companies list by Newsweek

    Ingevity Corporation (NYSE:NGVT) today announced it has been named to Newsweek's America's Most Responsible Companies list for the fourth consecutive year. The 2026 award recognizes the 600 top publicly traded companies in the United States for strong performance across corporate responsibility standards. "Being recognized on Newsweek's 2026 list of America's Most Responsible Companies is a proud moment for Ingevity," said Dave Li, President and CEO, Ingevity. "This honor reflects the integrity and care our teams bring to everything we do. By staying true to responsible growth and strengthening the communities we serve, we're building a resilient foundation for long-term success." The 2

    1/20/26 9:00:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces successful completion of sale of North Charleston crude tall oil refinery and majority of Industrial Specialties product line

    Transaction reduces portfolio volatility, strengthens Ingevity's margin and cash flow profile and enhances strategic flexibility Ingevity Corporation (NYSE:NGVT) today announced the completion of the previously disclosed sale of its North Charleston Crude Tall Oil (CTO) refinery assets and the majority of its Performance Chemicals Industrial Specialties product line to Mainstream Pine Products, LLC (Mainstream). Per the terms of the agreement, the all-cash transaction includes $110 million at closing plus potential contingent consideration ranging from $0 to $19 million, subject to the achievement of future business performance milestones. The transaction is subject to customary adjustmen

    1/5/26 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Financials

    Live finance-specific insights

    View All

    Ingevity announces dates for fourth quarter and full year 2025 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its fourth quarter and full year 2025 earnings after the stock market close on Wednesday, February 25, 2026. The company will host a live webcast on Thursday, February 26, at 10:00 a.m. (Eastern) to discuss fourth quarter and full year 2025 fiscal results. The webcast can be accessed via the investors section of Ingevity's website. Participants may pre-register for the event here. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 102386. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recordin

    2/11/26 9:15:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces results of portfolio review, including plans to explore strategic alternatives for Advanced Polymer Technologies segment and Road Markings business

    Potential divestitures would further enhance portfolio to focus on core businesses which carry best-in-class margins and cash flow generation Ingevity Corporation (NYSE:NGVT) today announced it has completed the company's previously disclosed portfolio review process and is in the early stages of exploring strategic alternatives for its Advanced Polymer Technologies (APT) segment and Performance Chemicals Road Markings business, including a potential sale of one or both. "Ingevity's leadership team and Board remain focused on unlocking long-term value for shareholders," said Dave Li, president and CEO of Ingevity. "Having conducted a thorough review of the Ingevity portfolio, we have dete

    12/8/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces dates for third quarter 2025 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its third quarter 2025 earnings after the stock market close on Wednesday, November 5, 2025. The company will host a live webcast on Thursday, November 6, at 10:00 a.m. (Eastern) to discuss third quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 871022. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on Novem

    10/23/25 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Leadership Updates

    Live Leadership Updates

    View All

    Ingevity announces key leadership transitions

    Ingevity Corporation (NYSE:NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future. Chief financial officer transition Mary Dean Hall, executive vice president and chief financial officer (CFO), will transition from her current role effective May 1, 2026, and continue to support the company in an advisory capacity for a period of one year. Hall has served as CFO since 2021, playing a critical role in strengthening Ingevity's financial foundation, enhancing operational discipline and supporting strategic growth initiatives. Under her financial leadership, the company achieved significant margin expan

    12/8/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity names Ruth Castillo as senior vice president and president of Performance Materials

    Veteran industry leader joins Ingevity to accelerate innovation and strategic growth across company's high performance activated carbon portfolio Ingevity Corporation (NYSE:NGVT) today announced that, effective November 10, 2025, Ruth Castillo has been appointed as president of Performance Materials, the company's unique activated carbon segment which has a long track record of consistent strong financial performance. She will also join Ingevity's executive leadership team as senior vice president. Castillo most recently served as vice president of global chemicals at Avantor. She brings more than 25 years of global experience in the chemicals and materials industries, with proven abili

    10/23/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces departure of Performance Materials segment president, Ed Woodcock

    Ingevity Corporation (NYSE:NGVT) today announced Ed Woodcock, executive vice president and president, Performance Materials, departed the company effective July 1, 2025. Woodcock's departure follows a 37-year career with the company. "Ed Woodcock's leadership has been foundational to the successful growth of Ingevity's Performance Materials activated carbon business as the industry leader in automotive emissions capture," said Ingevity president and CEO, Dave Li. "During his extensive career with the company, Ed drove global expansion of the business, delivered consistently strong profitability and positioned the Performance Materials segment for growth in the hybrid and electric vehicle

    7/1/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/12/24 3:54:24 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/4/24 11:52:25 AM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form SC 13D/A filed by Ingevity Corporation (Amendment)

    SC 13D/A - Ingevity Corp (0001653477) (Subject)

    2/28/24 5:30:32 PM ET
    $NGVT
    Major Chemicals
    Industrials